Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France

• Auteurs principaux: Cotté François-Emery (Auteur), De Pouvourville Gérard (Auteur)
• Format: Livre
• Publié: BMC, 2011-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>During the last decade, oral bisphosphonates (BP) became the most widely prescribed pharmacologic class for post-menopausal osteoporosis. However, many surveys revealed the important issue of poor persistence with those drugs resulti...